Atlas Trials

[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging

Clinical trial NCT03242993 · COMPLETED

Trial details

NCT number
NCT03242993
Sponsor
University of Lausanne Hospitals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Cancer LungMetastatic Ovarian Cancer
Start date
2017-04-01
Primary completion
2019-06-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.